Megan Sniecinski
Corporate Officer/Principal chez PRAXIS PRECISION MEDICINES, INC.
Profil
Megan Sniecinski is currently the Chief Business Officer at Praxis Precision Medicines, Inc. She previously held the position of Chief of Staff & Director-Strategic Partnerships at Merck Vaccine Division from 2011 to 2014.
From 2019 to 2021, she served as the Chief Business Officer & Senior Vice President at BioCryst Pharmaceuticals, Inc. Prior to that, she was the Senior VP-Business Operations & Program Management at PTC Therapeutics, Inc. from 2014 to 2019.
Ms. Sniecinski completed her undergraduate degree at the University of Virginia and holds an MBA from The Wharton School of the University of Pennsylvania.
Postes actifs de Megan Sniecinski
| Sociétés | Poste | Début |
|---|---|---|
| PRAXIS PRECISION MEDICINES, INC. | Corporate Officer/Principal | 02/12/2021 |
Anciens postes connus de Megan Sniecinski
| Sociétés | Poste | Fin |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 09/08/2021 |
| PTC THERAPEUTICS, INC. | Corporate Officer/Principal | 01/06/2019 |
| Merck Vaccine Division | Human Resources Officer | 01/09/2014 |
Formation de Megan Sniecinski
| University of Virginia | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
| PTC THERAPEUTICS, INC. | Health Technology |
| PRAXIS PRECISION MEDICINES, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
| Merck Vaccine Division |
